CYP cynata therapeutics limited

Ann: Investor Presentation, page-551

  1. 4,186 Posts.
    lightbulb Created with Sketch. 1487
    Good to see some very good annalise without the personal attacks.

    The error.

    "To recap old research - 11 patients only from GVHD001 got cells each from a single lot. (Silviu talks about a slide at ODAC to that effect). Only three donors were used. (Geraldine Stornton ODAC). Two of those 11 patients show no or very little reduction in T cell activity measured in blood of patients 28 days apart with the first blood being just before first treatment. (me looking at the graphic"

    This statement is at odds to the chart that summaries the data. 11 lots were used in 001. Two lots showed no change in T cells compared to entry levels.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.